SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-045553
Filing Date
2020-10-01
Accepted
2020-10-01 16:50:03
Documents
12
Period of Report
2020-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K rcus-8k_20201001.htm   iXBRL 8-K 36287
  Complete submission text file 0001564590-20-045553.txt   166631

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rcus-20201001.xsd EX-101.SCH 5776
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcus-20201001_lab.xml EX-101.LAB 19466
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcus-20201001_pre.xml EX-101.PRE 11627
5 EXTRACTED XBRL INSTANCE DOCUMENT rcus-8k_20201001_htm.xml XML 3547
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 201216788
SIC: 2834 Pharmaceutical Preparations